U.S. Blood Pressure Monitoring Devices Market Summary

The U.S. blood pressure monitoring devices market size was estimated at USD 3.8 billion in 2024 and is projected to reach USD 6.7 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2030. The market's upward trajectory is primarily driven by the increasing prevalence of hypertension worldwide, largely linked to evolving lifestyles that include poor dietary habits, stress, lack of physical activity, and other risk factors. As public awareness surrounding cardiovascular health continues to rise, the need for regular blood pressure monitoring has become more prominent among healthcare providers and individuals alike.

According to the World Health Organization (WHO) estimates published in 2019, approximately 1.28 billion people globally are affected by hypertension, making it one of the leading causes of premature mortality. This significant health burden underscores the increasing importance of blood pressure monitoring devices in both clinical and home settings. The expanding global geriatric population and growing incidence of lifestyle-related diseases such as obesity and diabetes further amplify the demand for easy-to-use, reliable monitoring tools that allow for early detection and better management of blood pressure-related conditions.

Key Market Trends & Insights

  • North America dominated the global blood pressure monitoring devices market in 2024, holding a revenue share of over 36.0%. This regional dominance is supported by well-established healthcare infrastructure, rising healthcare spending, increasing awareness among the population, and higher adoption of preventive healthcare technologies. The United States contributed a significant portion to this regional market share, benefiting from widespread use of home monitoring devices and the growing emphasis on managing chronic conditions through early diagnosis and regular tracking.
  • Based on device type, the non-smart/traditional segment accounted for the largest revenue share in 2024, representing over 56.7% of the market. This segment’s dominance is attributed to its affordability, ease of use, and broad accessibility in both developing and developed nations. Traditional devices continue to be preferred in many clinical environments due to their reliability and long-standing presence in the healthcare system, especially in situations where advanced smart features are not essential or cost-effective.
  • The market is further segmented by end use, including hospitals, ambulatory surgical centers, and home care settings. Hospitals continue to be key adopters of blood pressure monitoring devices due to their need for accurate and consistent monitoring in critical care and general patient assessments. Ambulatory surgical centers also rely on such devices to monitor vital signs during procedures, while home care is rapidly gaining popularity as individuals increasingly seek personal health management tools that offer convenience, autonomy, and consistent health tracking outside of clinical environments.

Order a free sample PDF of the U.S. Blood Pressure Monitoring Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2024 Market Size: USD 3.8 Billion
  • 2030 Projected Market Size: USD 6.7 Billion
  • CAGR (2025-2030): 9.8%
  • North America: Largest market in 2024

Key Companies & Market Share Insights

The global market for blood pressure monitoring devices is witnessing intense competition as it is price-sensitive. The companies are adopting competitive strategies such as mergers & acquisitions, strategic alliances, collaborative agreements, and partnerships to sustain the competition. The industry growth is directly associated with the rising investments by manufacturers to develop cost-effective, innovative, and easy-to-use products.

Key Players

  • Omron Healthcare
  • Welch Allyn, Inc.
  • A&D Medical Inc.
  • SunTech Medical, Inc.
  • American Diagnostics Corporation
  • Withings
  • Briggs Healthcare
  • GE Healthcare
  • Kaz Inc.
  • Microlife AG
  • Rossmax International Ltd.
  • GF Health Products Inc.
  • Spacelabs Healthcare Inc.
  • Philips Healthcare.
  • B. Braun SE

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

In conclusion, the global blood pressure monitoring devices market is poised for robust growth driven by the rising prevalence of hypertension, aging populations, and the adoption of preventive healthcare practices. With North America leading in revenue share and traditional device types remaining dominant, the market is witnessing increased demand across hospitals, surgical centers, and home care settings. Lifestyle factors such as obesity and sedentary habits continue to fuel demand for regular monitoring solutions. As awareness and technology adoption grow, the role of reliable blood pressure monitoring devices will remain crucial in managing chronic conditions and improving global cardiovascular health outcomes.